Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Short Interest Update

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) saw a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 7,300 shares, an increase of 102.8% from the February 28th total of 3,600 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 73.0 days.

Santhera Pharmaceuticals Stock Performance

Shares of SPHDF remained flat at $17.01 during mid-day trading on Friday. The stock’s fifty day simple moving average is $11.37 and its 200 day simple moving average is $11.06. Santhera Pharmaceuticals has a twelve month low of $16.00 and a twelve month high of $17.01.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).